51316-210-02 : NDC 2026 Code

51316-210-02 : Naloxone Hydrochloride ( Naloxone Hydrochloride )

Additionally :

You can get information about “51316-210-02” NDC code in 51316-210-02 in HTML format

HTML | 51316-210-02 in TXT (Plain Text) format

TXT | 51316-210-02 in PDF (Portable Document Format)

PDF | 51316-210-02 in XML format

XML formats.

NDC Code : 51316-210-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "51316-210-02",
    "PackageDescription": "2 VIAL in 1 CARTON (51316-210-02)  / .1 mL in 1 VIAL (51316-210-01) ",
    "NDC11Code": "51316-0210-02",
    "ProductNDC": "51316-210",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Naloxone Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Naloxone Hydrochloride",
    "DosageFormName": "SPRAY",
    "RouteName": "NASAL",
    "StartMarketingDate": "20240424",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA217992",
    "LabelerName": "CVS Pharmacy, Inc",
    "SubstanceName": "NALOXONE HYDROCHLORIDE",
    "StrengthNumber": "4",
    "StrengthUnit": "mg/.1mL",
    "Pharm_Classes": "Opioid Antagonist [EPC], Opioid Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-10-22",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20240424",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}